Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial
Stephen E. Gitelman, Peter A. Gottlieb, Mark R. Rigby, Eric I. Felner, Steven M. Willi, Lynda K. Fisher, Antoinette Moran, Michael Gottschalk, Wayne V. Moore, Ashley Pinckney, Lynette Keyes-Elstein, Sudeepta Aggarwal, Deborah Phippard, Peter H. Sayre, Linna Ding, Jeffrey A. Bluestone, Mario R. Ehlers
Dive into the research topics of 'Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial'. Together they form a unique fingerprint.